| P2093 | author name string | James T Rosenbaum | |
| | Sirichai Pasadhika | |
| P2860 | cites work | Intravitreal bevacizumab for treatment of uveitic macular edema | Q79960243 |
| | Unilateral periorbital oedema due to sarcoid infiltration of the eyelid: an unusual presentation of sarcoidosis with facial nerve palsy and parotid gland enlargement | Q80298428 |
| | Cyclosporine for conjunctival sarcoidosis | Q80425520 |
| | Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial | Q81059776 |
| | A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis | Q81371522 |
| | Analysis of pediatric uveitis cases at a tertiary referral center | Q81793650 |
| | Systemic sarcoidosis manifested as unilateral eyelid retraction | Q83137167 |
| | [Bilateral large conjunctival tumours as primary manifestation of sarcoidosis--successful treatment with steroid-depot-injections] | Q83202914 |
| | Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study | Q83321961 |
| | Ocular involvement in sarcoidosis | Q83765060 |
| | Infliximab therapy for refractory uveitis: 2-year results of a prospective trial | Q84022834 |
| | [Pulmonary and renal involvement in a TNFα antagonist drug-induced sarcoidosis] | Q84141286 |
| | Scleral nodule and bilateral disc edema as a presenting manifestation of systemic sarcoidosis | Q84251447 |
| | Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy | Q84279738 |
| | Sarcoidosis presenting as acute bulbar follicular conjunctivitis | Q84759889 |
| | Neuro-ophthalmic sarcoidosis | Q84800327 |
| | Golimumab for uveitis | Q84884711 |
| | Tumor Necrosis Factor-Alpha Antagonist-Induced Sarcoidosis | Q84971393 |
| | Golimumab treatment for complicated uveitis | Q85919466 |
| | THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion | Q86883039 |
| | Thalidomide for recalcitrant nodular scleritis in sarcoidosis | Q87475291 |
| | Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop | Q24727581 |
| | Non-invasive detection of multinucleated giant cells in the conjunctiva of patients with sarcoidosis by in-vivo confocal microscopy | Q33254095 |
| | Hypopyon in patients with uveitis | Q33518200 |
| | Cyclosporine for ocular inflammatory diseases | Q33520584 |
| | Mycophenolate mofetil for ocular inflammation | Q33521396 |
| | Fundus changes in histologically confirmed sarcoidosis | Q33641147 |
| | Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience | Q33757440 |
| | Ocular involvement in sarcoidosis | Q33803813 |
| | HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites | Q33905995 |
| | Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. | Q33920749 |
| | Epidemiology and course of disease in childhood uveitis | Q34118555 |
| | Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis | Q34258708 |
| | Characteristics of uveitic glaucoma and evaluation of its surgical treatment | Q34610591 |
| | The expression of STAT-1 and phosphorylated STAT-1 in conjunctival granulomas | Q34867606 |
| | Mycophenolate mofetil therapy for sarcoidosis-associated uveitis | Q34991196 |
| | Aqueous cell differentiation in anterior uveitis using Fourier-domain optical coherence tomography | Q35140336 |
| | Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients | Q35553908 |
| | Regulation of macrophage activation | Q35587947 |
| | Nodular scleritis in a patient with sarcoidosis | Q35590830 |
| | Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis | Q35904466 |
| | Scleritis associated with sarcoidosis | Q35932238 |
| | Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study | Q36089582 |
| | Peripheral ulcerative keratitis in sarcoidosis: a case report | Q36510814 |
| | Full-thickness eyelid lesions in sarcoidosis. | Q36879810 |
| | Diverse clinical presentations of orbital sarcoid | Q36942315 |
| | Methotrexate for ocular inflammatory diseases | Q37204512 |
| | Parallel Gene Expression Changes in Sarcoidosis Involving the Lacrimal Gland, Orbital Tissue, or Blood. | Q37253321 |
| | Hypothesis: sarcoidosis is a STAT1-mediated disease | Q37323719 |
| | Visual hallucinations (Charles Bonnet syndrome) associated with neurosarcoidosis | Q37346432 |
| | Azathioprine for ocular inflammatory diseases | Q37366679 |
| | Long-term visual prognosis of peripheral multifocal chorioretinitis. | Q53636110 |
| | The ocular and systemic prognosis of patients presenting with sarcoid uveitis | Q61054138 |
| | Sarcoidosis with optic nerve and retinal involvement | Q67754054 |
| | Course and outcome of ocular sarcoidosis | Q67945312 |
| | Risk factors for ocular sarcoidosis | Q69447579 |
| | Ocular involvement in chronic sarcoidosis | Q69607003 |
| | Conjunctival biopsy in sarcoidosis | Q70047295 |
| | Conjunctival biopsy as an aid in the evaluation of the patient with suspected sarcoidosis | Q71248916 |
| | Posterior scleritis with annular ciliochoroidal detachment | Q71552687 |
| | Interstitial Keratitis as Presenting Ophthalmic Sign of Sarcoidosis in a Child | Q71962550 |
| | Sarcoidosis of the eyelid skin | Q72419438 |
| | Conjunctival deposits as an initial manifestation of sarcoidosis | Q73052501 |
| | Central nervous system sarcoidosis--diagnosis and management | Q77344804 |
| | Lacrimal bypass surgery in patients with sarcoidosis | Q77370310 |
| | Isolated sarcoidosis of the lacrimal sac without systemic manifestations | Q77488662 |
| | Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents | Q77567415 |
| | Sarcoidosis presenting as multilobular limbal corneal nodules | Q77671439 |
| | Methotrexate treatment for sarcoid-associated panuveitis | Q77902774 |
| | Sarcoid of the fundus | Q78853234 |
| | Pediatric granulomatous arthritis: an international registry | Q79158593 |
| | Conjunctival biopsy in the diagnosis of sarcoidosis | Q79354704 |
| | Keratoconjunctivitis sicca due to sarcoidosis | Q37393204 |
| | THE EYES IN SARCOIDOSIS. | Q37401901 |
| | Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases | Q37474072 |
| | International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). | Q37544507 |
| | Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases | Q37604625 |
| | Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases | Q37698865 |
| | The eye as a common site for the early clinical manifestation of sarcoidosis | Q37811725 |
| | Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis | Q37863974 |
| | Certolizumab-induced uveitis: a case report and review of the literature | Q38202641 |
| | Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review. | Q38257387 |
| | Sarcoid choroiditis simulating birdshot chorioretinopathy | Q38267575 |
| | Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey | Q39373498 |
| | Pediatric ocular sarcoidosis | Q39499951 |
| | Sarcoidosis during infliximab therapy for Crohn's disease | Q40356811 |
| | A case of CNS sarcoidosis -case report of hydrocephalus due to mechanical obstruction secondary to sarcoid granulomata at the outlet of the fourth ventricle (author's transl) | Q40856347 |
| | EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA. | Q41290783 |
| | Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis | Q41457227 |
| | Scleritis: a clinicopathologic study of 55 cases | Q41679272 |
| | A case of macular subretinal neovascularisation in chronic uveitis probably caused by sarcoidosis | Q41819281 |
| | Sarcoidosis of the eyelid skin. | Q41943546 |
| | A case of scar sarcoidosis of the eyelid | Q42147162 |
| | Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial | Q42276574 |
| | Symblepharon in Sarcoidosis | Q43466957 |
| | Intraocular manifestations of systemic sarcoidosis | Q43490894 |
| | Destructive eyelid lesions in sarcoidosis | Q43561678 |
| | Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases | Q44557227 |
| | Topical cyclosporin in the treatment of chronic sarcoidosis of the conjunctiva | Q44578245 |
| | Cicatricial conjunctivitis in sarcoidosis: recognition and treatment | Q45037175 |
| | Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab). | Q45075976 |
| | Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients | Q45184183 |
| | Conjunctival non-caseating granulomas in a human immunodeficiency virus (HIV) positive patient attributed to sarcoidosis | Q45410841 |
| | Ranibizumab for refractory uveitis-related macular edema. | Q46018981 |
| | Treatment of sarcoidosis with infliximab | Q46375478 |
| | Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. | Q46481520 |
| | Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis | Q46549629 |
| | A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. | Q46595124 |
| | Retinal changes in sarcoidosis | Q46708564 |
| | Eyelid swelling as the only manifestation of ocular sarcoidosis | Q46898732 |
| | Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis | Q46955634 |
| | Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants | Q46960505 |
| | Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. | Q48268818 |
| | Uveitis in the southeastern United States. | Q50936319 |
| | Referral patterns of uveitis in a tertiary eye care center. | Q51034605 |
| | Orbital and adnexal sarcoidosis. | Q51724461 |
| | Prognosticators for visual outcome in sarcoid uveitis. | Q52292819 |
| | Vision Loss After Central Retinal Artery Occlusion Secondary to Orbital Sarcoid Mass. | Q53058620 |
| | Choroidal thickness in ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography. | Q53063437 |
| P433 | issue | 4 | |
| P304 | page(s) | 669-683 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Clinics in Chest Medicine | Q15754921 |
| P1476 | title | Ocular Sarcoidosis. | |
| P478 | volume | 36 | |